Last10K.com

Nucana Plc (NCNA) SEC Filing 6-K Foreign Issuer report for the period ending Saturday, June 30, 2018

Nucana Plc

CIK: 1709626 Ticker: NCNA

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2018

(Commission File No. 001-38215)

 

 

NUCANA PLC

(Translation of registrant’s name into English)

 

 

3 Lochside Way

Edinburgh EH12 9DT

United Kingdom

(Address of registrant’s principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒                 Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):  ☐

 

 

 


The information in the attached Exhibits 99.1 and 99.2 shall be deemed to be incorporated by reference into the Company’s Registration Statement on Form S-8 (Registration Number 333-223476) and any related prospectuses, as such Registration Statement and prospectuses may be amended from time to time, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibits

 

Exhibit No.

  

Description

99.1    Unaudited Condensed Consolidated Financial Statements as of June 30, 2018 and for the Three and Six Months Ended June 30, 2018 and 2017
99.2    Management’s Discussion and Analysis for the Three and Six Months Ended June 30, 2018 and 2017
101    The following materials from this Report on Form 6-K formatted in XBRL (eXtensible Business Reporting Language): (i) Unaudited Condensed Consolidated Statements of Operations for the Three and Six Month Periods ended June 30, 2018 and 2017, (ii) Unaudited Condensed Consolidated Statements Comprehensive Loss for the Three and Six Month periods ended June 30, 2018 and 2017 (iii) Unaudited Condensed Consolidated Statements of Financial Position as at June 30, 2018 and December 31, 2017, (iv) Unaudited Condensed Consolidated Statements of Changes in Equity for the Six Month Periods ended June 30, 2018 and 2017, (v) Unaudited Condensed Consolidated Statements of Cash Flows for the Six Month Periods ended June 30, 2018 and 2017 and (vi) Notes to the Unaudited Condensed Consolidated Financial Statements.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

NuCana plc
By:   /s/ Donald Munoz
Name:   Donald Munoz
Title:   Chief Financial Officer

Date: October 1, 2018

View differences made from one to another to evaluate Nucana Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nucana Plc.

Continue

Assess how Nucana Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nucana Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 6-K Foreign Issuer Report

Document And Entity Information
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Changes In Equity
Condensed Consolidated Statements Of Comprehensive Loss
Condensed Consolidated Statements Of Financial Position
Condensed Consolidated Statements Of Operations
Basic And Diluted Loss Per Share
Basic And Diluted Loss Per Share (Tables)
Basic And Diluted Loss Per Share - Schedule Of Basic And Diluted Loss Per Share (Detail)
Cash And Cash Equivalents
Cash And Cash Equivalents (Tables)
Cash And Cash Equivalents - Schedule Of Detailed Information About Cash And Cash Equivalents (Detail)
Contingent Liabilities
Contingent Liabilities - Additional Information (Detail)
General Information
General Information - Additional Information (Detail)
Income Tax
Income Tax (Tables)
Income Tax - Additional Information (Detail)
Income Tax - Schedule Of Major Components Of Income Tax Assets (Detail)
Income Tax - Schedule Of Major Components Of Income Tax Credit (Detail)
Intangible Assets
Intangible Assets - Additional Information (Detail)
Ipo Related Expenses
Ipo Related Expenses (Tables)
Ipo Related Expenses - Summary Of Initial Public Offering Related Expenses (Detail)
Share Based Payments - Additional Information (Detail)
Share Based Payments - Summary Of Principal Assumptions Used For Valuation Of Share Options (Detail)
Share Capital And Share Premium
Share Capital And Share Premium (Tables)
Share Capital And Share Premium - Summary Of Movement In The Share Capital (Detail)
Share Capital And Share Premium - Summary Of Share Capital And Share Premium (Detail)
Share Capital And Share Premium - Summary Of Share Capital And Share Premium (Parenthetical) (Detail)
Share-Based Payments
Share-Based Payments (Tables)
Significant Accounting Policies
Significant Accounting Policies (Policies)
Significant Accounting Policies - Additional Information (Detail)

Material Contracts, Statements, Certifications & more

Nucana Plc provided additional information to their SEC Filing as exhibits

Ticker: NCNA
CIK: 1709626
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-18-288616
Submitted to the SEC: Mon Oct 01 2018 12:00:00 AM EST
Accepted by the SEC: Mon Oct 01 2018
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ncna/0001193125-18-288616.htm